Passa al contenuto
Merck
  • CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.

Oncogene (2017-09-12)
Q Tu, J Hao, X Zhou, L Yan, H Dai, B Sun, D Yang, S An, L Lv, B Jiao, C Chen, R Lai, P Shi, X Zhao
ABSTRACT

Pancreatic cancer is among the deadliest malignancies; however, the genetic events that lead to pancreatic carcinogenesis in adults remain unclear. In vivo models in which these genetic alterations occur in adult animals may more accurately reflect the features of human cancer. In this study, we demonstrate that inactivation of Cdkn2b (p15ink4b) is necessary for induction of pancreatic cancer by oncogenic KRAS

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
TRI reagent®, For processing tissues, cells cultured in monolayer or cell pellets
Sigma-Aldrich
Polietilenimina, ramificata, average Mw ~25,000 by LS, average Mn ~10,000 by GPC, branched